Pathogenesis

Ho Discusses Problem of Elusive HIV/AIDS Cure at Major Conference

Published in AIDS Weekly, August 7th, 2000

Laboratory studies in the past five years have armed researchers and clinicians with significant tools in the development of therapies to treat HIV affected individuals.

Dr. David Ho, scientific director and chief executive officer of the Aaron Diamond AIDS Research Center in New York, an affiliate of Rockefeller University, discussed the current AIDS landscape on at the 52nd Annual Meeting of the American Association for Clinical Chemistry (AACC), held in San Francisco, California, July 23-27, 2000.

What has been learned about AIDS in the past five years has had a significant effect on therapeutic strategies. Because HIV can generate mutant...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2000-08-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry